81379 München Germany daiichi-sankyo.eu +498978080 × +− Leaflet|©OpenStreetMap Newsletter From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. ...
“In today’s business environment, data is like oxygen. We breathe it every day, it’s vital for our survival and progress,” said Pavel Ermakov, Head of Data Excellence at Daiichi Sankyo Europe. “Amidst the data deluge, one thing is paramount: trust. Trust in the pristine quality and...
Daiichi Sankyo is an innovative global healthcare company based in Japan underpinned by its Purpose: “To contribute to the enrichment of quality of life around the world”.
Since fiscal year 2016, Daiichi Sankyo Europe GmbH has introduced a mobility concept for employees to select safe and secure modes of commuting with low environmental burdens. By encouraging employees to select their own mode of transportation, such as a combination of bicycle, public transportation,...
Daiichi Sankyo Co., Ltd. (Tokyo, Japan) High resolution image Low resolution image Daiichi Sankyo Europe GmbH (Munich, Germany) High resolution image Low resolution image People Ken Keller Chairman of the Board, President and Chief Executive Officer of Daiichi Sankyo, Inc. and Global Head of th...
DAIICHI SANKYO EUROPE GmbH
Germany Bayern Biotech, Daiichi Sankyo Europe Gmbh, daiichi sankyo group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets. with over
Daiichi Sankyo Co., Ltd. (Tokyo, Japan) High resolution image Low resolution image Daiichi Sankyo Europe GmbH (Munich, Germany) High resolution image Low resolution image People Ken Keller Chairman of the Board, President and Chief Executive Officer of Daiichi Sankyo, Inc. and Global Head of th...
DAIICHI SANKYO EUROPE GMBH于申请了名称为MOBILISIN的第5类商标,商标注册号为G626780,由国际局代理申请。
The present invention relates to binding proteins that bind to HER-3 and polynucleotides encoding the same. Expression vectors and host cells comprising the same for the production of the binding protein of the invention are also provided. In addition, the invention provides compositions and methods...